- Home
- FFNW vs NPCE Comparison
FFNW vs NPCE Comparison
Compare FFNW & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFNW
- NPCE
- Stock Information
- Founded
- FFNW 1923
- NPCE 1997
- Country
- FFNW United States
- NPCE United States
- Employees
- FFNW N/A
- NPCE N/A
- Industry
- FFNW Banks
- NPCE Medical Specialities
- Sector
- FFNW Finance
- NPCE Health Care
- Exchange
- FFNW Nasdaq
- NPCE Nasdaq
- Market Cap
- FFNW 203.8M
- NPCE 217.5M
- IPO Year
- FFNW N/A
- NPCE 2021
- Fundamental
- Price
- FFNW $22.47
- NPCE $9.00
- Analyst Decision
- FFNW Hold
- NPCE Buy
- Analyst Count
- FFNW 3
- NPCE 7
- Target Price
- FFNW $23.00
- NPCE $15.71
- AVG Volume (30 Days)
- FFNW 25.4K
- NPCE 119.2K
- Earning Date
- FFNW 10-29-2024
- NPCE 11-12-2024
- Dividend Yield
- FFNW 2.30%
- NPCE N/A
- EPS Growth
- FFNW N/A
- NPCE N/A
- EPS
- FFNW 0.12
- NPCE N/A
- Revenue
- FFNW $37,168,000.00
- NPCE $76,452,000.00
- Revenue This Year
- FFNW N/A
- NPCE $20.21
- Revenue Next Year
- FFNW $2.64
- NPCE $15.04
- P/E Ratio
- FFNW $194.89
- NPCE N/A
- Revenue Growth
- FFNW N/A
- NPCE 27.00
- 52 Week Low
- FFNW $11.20
- NPCE $5.45
- 52 Week High
- FFNW $23.50
- NPCE $18.15
- Technical
- Relative Strength Index (RSI)
- FFNW 51.19
- NPCE 64.58
- Support Level
- FFNW $22.17
- NPCE $8.46
- Resistance Level
- FFNW $22.36
- NPCE $10.42
- Average True Range (ATR)
- FFNW 0.42
- NPCE 0.90
- MACD
- FFNW 0.01
- NPCE 0.18
- Stochastic Oscillator
- FFNW 47.10
- NPCE 67.65
About FFNW First Financial Northwest Inc.
First Financial Northwest Inc is the holding company. The Bank's business consists predominantly of attracting deposits from the general public, combined with borrowing from the FHLB of Des Moines and raising funds in the wholesale market then utilizing these funds to originate one-to-four family residential, multifamily, commercial real estate, construction/land, business, and consumer loans. The Bank's strategic initiatives seek to diversify its loan portfolio and broaden growth opportunities with its current risk tolerance levels and asset/liability objectives.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.